<!DOCTYPE html>
<html lang = "en-us">
<header>
  <img src="https://www.inflexion.org/wp-content/uploads/2016/03/Bill-Melinda-Gates-Foundation-Logo.svg_.png"
  alt="Bill-Melinda-Gates-Foundation-Logo" style="width:490.5px; height:102px">
</header>
<head>
  <nav>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<style>
body {margin: 0;
  background-image: url("https://i.imgur.com/rKUhvjj.jpg");
  font-size: 16px;
}
div {
    border: 1px solid gray;
    padding: 80px;
}

.sticky {
  position: fixed;
  top: 0;
  width: 100%;
}

div.sticky {
  position: -webkit-sticky;
  position: sticky;
  top: 0;
  padding: 5px;
  background-color: #cae8ca;
  border: 2px solid #4CAF50;
}

h1 {
    text-align: center;
    text-transform: uppercase;
    color: #4CAF50;
}

h2 {
    text-align: left;
    text-transform: uppercase;
    color: #4CAF50;
}

p {
    text-indent: 50px;
    text-align: justify;
    letter-spacing: 3px;
    text-shadow: 0.2px 0.2px black;
}


ul.topnav {
    list-style-type: none;
    margin: 0;
    padding: 0;
    overflow: hidden;
    background-color: #333;
}

div.gallery {
    margin: 5px;
    border: 1px solid #ccc;
    float: left;
    width: 205px;
}

div.gallery:hover {
    border: 1px solid #777;
}

div.gallery img {
    width: 100%;
    height: auto;
}

div.desc {
    padding: 10px;
    text-align: center;
}

ul.topnav li {float: left;}

ul.topnav li a {
    display: block;
    color: white;
    text-align: center;
    padding: 14px 16px;
    text-decoration: none;
}

ul.topnav li a:hover:not(.active) {background-color: #111;}

ul.topnav li a.Home:hover, a.Home:active {background-color: #4CAF50;}
ul.topnav li a.About:hover, a.About:active {background-color: #4CAF50;}
ul.topnav li a.Contact:hover, a.Contact:active {background-color: #4CAF50;}
ul.topnav li a.Request:hover, a.Request:active {background-color: #4CAF50;}
ul.topnav li a.Appointment:hover, a.Appointment:active {background-color: #4CAF50;}

ul.topnav li.right {float: right;}

@media screen and (max-width: 600px){
    ul.topnav li.right,
    ul.topnav li {float: none;}
}

.center {
    display: block;
    margin-left: auto;
    margin-right: auto;
    width: 50%;
}

</style>
</head>
<ul class="topnav">
  <li><a class="Home" href="home.htm"><p>Home</p></a></li>
  <li><a class="About" href="about.htm"><p>About the Vaccine</p></a></li>
  <li><a class="Contact" href="contactUs.htm"><p>Locate Us</p></a></li>
  <li><a class="Request" href="requestForm.htm"><p>Request Vaccine</p></a></li>
  <li><a class="Appointment" href="appointment.htm"><p>Doctor's Appointment</p></a></li>
</ul>
</nav>
<body>
  <div>
<h1>Welcome to our DefHacks Submission</h1>
<img src="http://defhacks.io/img/defhacks-logos/defhacks-wordmark-logo-white-green.png" alt="DefHacks logo" class="center">

  <h1>Malaria: A Killer</h1>
  <div class="sticky"><h2>Our Goal:</h2><p>to prevent more than 11 million deaths, 3.9 million disabilities,
    and 264 million illnesses by 2020 through high, equitable, and sustainable vaccine coverage and
    support for polio eradication.</p></div>
  <p> Malaria occurs in nearly 100 countries worldwide, exacting a huge toll
     on human health and imposing a heavy social and economic burden in developing countries,
     particularly in Sub-Saharan Africa and South Asia. An estimated 207 million people
    and about 627,000 died. About 90 percent of the suffered from the disease in 2012,
     deaths were in Sub-Saharan Africa, and 77 percent were among children under age 5. <br /><br />
Current tools and treatments are insufficient, however, to achieve elimination in many countries.
And the cost of maintaining these interventions has reached several billion dollars a year. The malaria
 parasite has begun to develop resistance to currently available insecticides and drugs, and these
 resistant strains will spread. Infected individuals who are asymptomatic—the majority of those infected
 —remain an ongoing source of transmission. <br /><br />Given sufficient global commitment, major
 investments in research and development, and transformative new tools and delivery strategies, the
 ambitious goal of malaria eradication can be met. Without an immediate, coordinated worldwide effort
 to eradicate malaria, this window of opportunity could close indefinitely and the progress already achieved
 will remain at risk.
  </p>
 <h1>Our Strategy</h1>
 <p>
 Malaria is a top priority of the Bill & Melinda Gates Foundation. Our new multi-year Malaria strategy, Accelerate
  to Zero, adopted in late 2013, addresses the areas in which we believe the foundation is best positioned, among
  a broad spectrum of partners, to develop groundbreaking approaches to reducing the burden of malaria and
  accelerating progress toward eradication of the disease. <br /><br />
  Our Malaria strategy is based on a core set of foundational principles that support our evolving strategic choices.
  <br /><br />
  <ul> <li><p>Malaria eradication is defined as removing the parasites that cause human malaria from the human population.
    Simply interrupting transmission is not sufficient to achieve eradication.</p></li>
    <li><p>Eradication can be accelerated by new drug regimens and strategies that lead to complete parasitologic cure of
      the individual. Current artemisinin-based regimens achieve only clinical cure of the individual and do not
      eliminate the forms of the parasites that are responsible for continued transmission.</p></li>
      <li><p>The majority of malaria infections occur in asymptomatic people, who are a source of continued transmission.
        A successful and accelerated eradication effort will target asymptomatic infections through community-based efforts.</p></li>
    <li><p>Emerging resistance to current drugs and insecticides is an immediate threat to recent gains and an obstacle
      to future progress. Use of current tools and development of new tools should be guided by this evolutionary imperative. </p></li>
  <li><p>Malaria is biologically and ecologically different throughout the world. Malaria eradication will depend on strategies
    developed and implemented on a local or regional level.</p>  </li><p>
    To date, we have committed nearly US$2 billion in grants to combat malaria. In addition, we have committed more than US$1.6 billion
     to the Global Fund to Fight AIDS, Tuberculosis and Malaria, which provides about 50 percent of international funding for malaria
     control worldwide. We also advocate for sustained and increased funding of malaria-related efforts by donor governments and endemic
     countries.
  </p>
  </div>

  <div class="gallery">
  <a target="_blank" href="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_EntimologistExaminesMosquito_450x300.jpg?la=en">
    <img src="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_EntimologistExaminesMosquito_450x300.jpg?la=en"
    alt="An entomologist examines dead mosquitoes extracted from a window trap in a village." width="300" height="200">
  </a>
  <div class="desc"><p>An entomologist examines dead mosquitoes extracted from a window trap in a village.</p></div>
</div>

<div class="gallery">
  <a target="_blank" href="https://www.gatesfoundation.org/~/media/GFO/Top-Banners/FC370682_pano_702x279.jpg?h=279&la=en&mw=702&w=702">
    <img src="https://www.gatesfoundation.org/~/media/GFO/Top-Banners/FC370682_pano_702x279.jpg?h=279&la=en&mw=702&w=702" alt="Forest" width="600" height="400">
  </a>
  <div class="desc"><p>Lab technicians conducting mosquito research at Ifakara Health Institute in Tanzania.</p></div>
</div>

<div class="gallery">
  <a target="_blank" href="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_NurseDispensesDrug_225x200.jpg?la=en">
    <img src="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_NurseDispensesDrug_225x200.jpg?la=en" alt="A nurse dispenses a malaria drug to
    treat an infected child in Tanzania." width="600" height="400">
  </a>
  <div class="desc"><p>A nurse dispenses a malaria drug to treat an infected child in Tanzania.</p></div>
</div>

<div class="gallery">
  <a target="_blank" href="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_RuralResidentsCambodia_225x200.jpg?la=en">
    <img src="https://www.gatesfoundation.org/~/media/GFO/What-We-Do/MAL_RuralResidentsCambodia_225x200.jpg?la=en" alt=
    "Rural residents of Pailin Province, Cambodia, attend a course on malaria prevention." width="600" height="400">
  </a>
  <div class="desc"><p>Rural residents of Pailin Province, Cambodia, attend a course on malaria prevention.</p></div>
</div>
</body>
</html>
